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positively correlates with increased
diagnosis of thyroid cancer in South Korean
patients
Yoon Jae Cho1†, Do Young Kim1†, Eun-Cheol Park2,3 and Kyu-Tae Han2,4*Abstract
Background: The incidence of thyroid cancer among South Koreans is more than 10-fold greater than its incidence
in other countries, although its associated mortality rate is similar. Amidst concerns regarding the over-diagnosis of
thyroid cancer related to gradually expanded medical testing in South Korea, we hypothesized that the number of
thyroid fine-needle aspiration biopsies has led to increased diagnosis of thyroid cancer.
Methods: We used data from the National Health Insurance Service National Sample Cohort 2003–2013, which
included all medical claims filed for the 1,122,456 people in a nationally representative sample. We performed a
Poisson regression analysis using generalized estimating equation to investigate the relationship between the
number of thyroid fine-needle aspiration biopsies and the newly diagnosed cases of thyroid cancer.
Results: The study included 60 annual patients per 100,000 individuals out of 11,024,548 person-years. The number
of biopsies per 100,000 patients positively correlated with increased incidence of thyroid cancer diagnosis (per 100
biopsy cases: RR = 1.108; 95% CI: 1.090–1.126; P < 0.0001). Such relationships were greater in males, patients with a
higher socioeconomic status, and patients from regions with relatively less accessibility to biopsies.
Conclusion: Our findings suggest that a higher number of thyroid fine-needle aspiration biopsies per 100,000
individuals in a specific Si-Gun-Gu is positively associated with excessively increased diagnosis of thyroid cancer.
Regarding the continually increasing thyroid cancer incidence in South Korea, healthcare professionals and policy
makers should consider proper guidelines for recognizing the role of thyroid fine-needle aspiration biopsies in the
potential over-diagnosis of thyroid cancer.
Keywords: Thyroid cancer, Biopsy, Fine-needle, Health Services Accessibility, OverdiagnosisBackground
South Korea has experienced rapid modernization both
socially and economically, leading to the improved
health status of South Koreans but an increase of elderly
individuals [1, 2]. As a result, the dominant disease
patterns of South Koreans shifted from communicable
diseases to non-communicable diseases [3], such as* Correspondence: kthan@yuhs.ac
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(http://creativecommons.org/publicdomain/zecancer [4, 5]. Many South Koreans now participate in
preventive “health checkup” programs, which can posi-
tively affect cancer-related health outcomes. However,
increased medical testing has led to an unexpected chal-
lenge: the “over-diagnosis” of asymptomatic cancers in
South Korean individuals [6, 7].
Over-diagnosis occurs when a condition is diagnosed
that would otherwise not produce symptoms or cause
death [8] and has been tentatively observed with respect
to thyroid cancer [9]. According to GLOBOCAN, the in-
cidence of thyroid cancer in South Korea was more than
10-fold greater than in other countries, although its
mortality rate is similar (incidence: 52.8 per 100,000le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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ity: 0.5 per 100,000 individuals) [10, 11]. In addition, the
incidence has rapidly increased in South Korea (6.9 vs.
71.3 per 100,000 people in 2000 and 2013, respectively) in
parallel with increased medical utilization during this time
[12]. Therefore, many healthcare professionals have inves-
tigated the possible causes of such rapid increases. The in-
creased incidence of small papillary thyroid cancer with
an unchanged mortality rate [13, 14] suggests that it may
result due to more frequent thyroid cancer screenings,
improved diagnostic scrutiny, increased coverage of the
National Health Insurance (NHI), more accessibility to
ultrasonography, and certain environmental and genetic
factors [6, 15].
In South Korea, cancer screenings, including thyroid
biopsy, are often performed to confirm abnormal find-
ings based on ultrasonography or other clinical indica-
tions [16]. According to the National Health Insurance
Service (NHIS), the number of thyroid fine-needle aspir-
ation biopsies increased in parallel to the increase in newly
diagnosed cases of thyroid cancer [17]. Nevertheless, there
are no alternatives for controlling such increases in fine-
needle aspiration biopsy and thyroid cancer, and more
detailed studies are required to establish effective alterna-
tives for optimal management of thyroid cancer. We
hypothesized that the increase in biopsies could signifi-
cantly affect diagnosis of thyroid cancer, and possibly lead
to overdiagnosis. The current study aims to identify an
increase in the number of unnecessary thyroid fine-needle
aspiration biopsies, and to determine whether it contrib-
utes to increasing diagnosis of thyroid cancer.
Methods
Study population
The data used in this study were obtained from the
NHIS National Sample Cohort 2002–2013 released in
2014 and include a nationally representative random
sample of 1,025,340 individuals, approximately 2.2%
of the entire NHIS population in 2002. The data were
compiled by the NHIS using a systematic sampling
method to generate a representative sample of
46,605,433 Korean residents. The database includes all
medical claims filed from January 2002 to December
2013. To investigate the relationship between the
number of thyroid fine-needle aspiration biopsies in
each geographic region and newly diagnosed cases of
thyroid cancer, we excluded patients who were diag-
nosed with thyroid cancer (ICD-10: C73) before 2003.
We then identified patients who underwent a thyroid bi-
opsy (EDI code: C8591) and aggregated this number as a
unit of 253 basic administrative districts (Si-Gun-Gu; city-
county-ward) of South Korea. Data used in this study con-
sisted of 11,024,548 person-years of 1,122,456 individuals
during 2003–2013.Variables
Our outcome variable was the number of newly diag-
nosed cases of thyroid cancer during the study period,
indicated by the first hospital visit during which thyroid
cancer (ICD-10: C73) was the major diagnosis for each
patient.
The primary independent variable was the number of
fine-needle aspiration biopsies performed in each Si-
Gun-Gu. We first identified whether patients received
thyroid needle aspiration biopsies based on EDI Code
and aggregated the number of biopsies as a unit of Si-
Gun-Gu per each year. We then calculated the number




Thyroid fine needle aspiration biopsy in Si−Gun−Gu
The number of population in Si−Gun−Gu
 100; 000
We also adjusted other independent variables when ana-
lyzing the association between the number of biopsies per
100,000 people and cases of newly diagnosed thyroid can-
cer. Other independent variables included sex, age, in-
come, type of insurance coverage, study year, region, and
the financial independence rate of the local government.
Ages were categorized as ≤19, 20–29, 30–39, 40–49, 50–
59, 60–69, 70–79, and ≥80 years to reflect differences in
diagnosis of thyroid cancer [18]. The types of insurance
coverage were categorized as medical aid, NHI employee
insurance, or NHI self-employed insurance based on NHI
criteria. Those with NHI employee insurance included
workers and employers in all workplaces, public officials,
private school employees, continuously insured persons,
and daily paid workers at construction sites. Beneficiaries
of NHI employee insurance included spouses, descen-
dants, siblings, and parents. Individuals with NHI em-
ployee insurance paid approximately 7% of their average
salary in contribution payments, though these rates usu-
ally changed annually. The NHI self-employed insurance
category included people whose contribution amount was
set based on their income, property, living standard, and
rate of participation in economic activities. Medical aid
beneficiaries were patients with an income below the
government-defined poverty level or who had a disability
and were provided with free in- and outpatient care via
government funds. Therefore, the type of insurance cover-
age represented each patient’s socioeconomic status [2].
We included this variable in the study to consider poten-
tial differences in the accessibility of thyroid cancer
screening according to socioeconomic status. The finan-
cial independence rate of the local government was an
index of the finance utilization capacity of a local govern-
ment with independent discretionary power, which was
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ment budgets × 100 [19].
Statistical analysis
We first examined the frequencies and percentages of
each categorical variable or the mean and standard devi-
ation of each continuous variable at each patient’s base-
line, respectively. We performed χ2 tests to analyze the
distribution of person-years for each categorical variable
by diagnosis of thyroid cancer and an analysis of vari-
ance (ANOVA) for each continuous variable by diagno-
sis during the study period. The tests were performed in
all study subjects and patients who received thyroid
biopsy, respectively. Finally, we performed Poisson re-
gression analysis using generalized estimating equations
(GEE) to investigate the relationship between the num-
ber of thyroid biopsies and cases of newly diagnosed thy-
roid cancer adjusting for sex, age, income, type of
insurance coverage, study year, region, and financial in-
dependence rate of regional government. GEE models
with link logit that included both patient- and region-
level variables were analyzed, as data used in this study
were hierarchically structured and had binary outcome
variables. This model assumed proper distributions for
each hospitalization case while taking into account the
correlation among individuals within the Si-Gun-Gu. In
this study, the correlation was an exchangeable correl-
ation structure [20]. To identify whether thyroid biopsies
were unnecessary for diagnosis of thyroid cancer, we also
analyzed the relationship between the number of thyroid
biopsies and newly diagnosed thyroid cancer cases only
among patients who received thyroid biopsies. The
goodness-of-fit for the GEE model was assessed using
the quasi-likelihood under the independence criterion
(QIC), whose lower value indicated the goodness-of-fit
[21]. In addition, we performed sub-group analyses for
Poisson regression analyses to compare differences in
the association between the number of biopsies and
cases of newly diagnosed thyroid cancer according to
sex, income, the median number of thyroid fine-needle
biopsies, and financial independence rate of the local
government. All statistical analyses were performed
using SAS version 9.4.
Results
The data used in this study were compiled from
1,122,456 people at baseline and represented 11,024,548
person-years during the study period. Additional file 1
shows the patients’ general characteristics, including
individual- and regional-level variables at baseline. The
average follow-up period of each person included in this
study was 9.82 person-years. The average number of thy-
roid fine-needle aspiration biopsies in each Si-Gun-Gu
at baseline was 73.16 per 100,000 individuals. Therewere generally more individuals in the lower age group
than in the older age groups. “NHI employed” was the
most common type of insurance coverage. Figure 1
shows trends of the incidence and mortality of thyroid
cancer during the study period. The incidence gradually
increased, but the mortality rate remained relatively
stable. Figure 2 shows the positive correlation between
number of thyroid fine-needle aspiration biopsies and
new diagnoses of thyroid cancer during the study period
(Spearman correlation coefficient: 0.48, P < 0.001).
Table 1 shows the associations between new cases of
thyroid cancer and each independent variable in this
study. We observed a 0.6% incidence rate (n = 6619 diag-
nosed patients) among 11,024,548 person-years, and the
average number of thyroid fine needle biopsies in Si-Gun-
Gu was greater in patients diagnosed with thyroid cancer
than in patients who were not diagnosed (Diagnosed
mean: 348.2, SD: 225.0; Non-diagnosed mean: 253.3, SD:
207.9; P < 0.0001). In addition, socioeconomic status had a
positive linear association with thyroid cancer diagnosis.
By region, patients from Jeollanam-do were more fre-
quently with thyroid cancer than patients from other re-
gions. On the other hand, in regards to patients with
thyroid biopsy, the average number of thyroid fine-needle
biopsies performed in Si-Gun-Gu was lower in patients di-
agnosed with thyroid cancer compared to others.
Table 2 shows the results of GEE Poisson regression
analyses for the entire population and for patients
with thyroid needle biopsy, respectively. In the whole
population, the number of biopsies per 100,000 indi-
viduals was positively associated with diagnosis of
thyroid cancer (per 100 cases: RR = 1.108, 95% CI:
1.090-1.126; P < 0.0001). The financial independence
rate of the local government was also positively associated
with increased diagnosis of thyroid cancer but it was not
statistically significant. Diagnosed cases of thyroid cancer
in females were 5-fold greater than males, and patients
40–59 years of age were more often diagnosed than pa-
tients of other age groups. Patients of higher socioeco-
nomic status showed a greater incidence of thyroid cancer
diagnosis. In addition, the risk in the diagnosis of thyroid
cancer was gradually increased by the year. In patients
who received thyroid biopsy, in contrast to results from
the entire population, the regional number of thyroid fine-
needle aspiration biopsy was inversely associated with the
diagnosis of thyroid cancer (per 100 cases: RR = 0.973,
95% CI: 0.952-0.995; P = 0.0143). In particular, patients
under 40 years of age were more often diagnosed than
patients in other age groups.
We also performed subgroup analyses to investigate
positive associations in the number of biopsies with thy-
roid cancer diagnoses according to sex, income, median
number of thyroid fine-needle biopsy, and financial inde-
pendence rate of local government (Fig. 3). In the whole
Fig. 1 Trends of annual thyroid cancer incidence and mortality during 2003–2013
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than females, in patients with incomes above the median
financial independence rate, and in subjects from regions
with lower biopsy frequencies than the median number.
On the other hand, for patients who received thyroid bi-
opsy, negative association was observed more in females
as well as in patients with incomes below the median
financial independence rate (Fig. 4).
Discussion
The rapid improvement of health status in South Korean
has created an “aging society” in which dominant healthFig. 2 Correlation between thyroid fine-needle aspiration biopsy frequency
was calculated as the number of thyroid fine-needle aspiration biopsy or dproblems and issues have shifted to non-communicable
diseases, such as cancer. Although many healthcare pro-
fessionals have prompted positive outcomes through im-
proved medical care [4], some concerns regarding the
over-diagnosis of certain diseases, such as thyroid can-
cer, have arisen and have been validated in previous
studies [7]. For example, previous studies suggest that
increased access to ultrasonography in South Korea
could contribute to increased cases of thyroid cancer [6].
However, questions remain regarding the environmental
and genetic factors that may prompt the over-diagnosis
of thyroid cancer.and diagnosis of thyroid cancer during 2003–2013. *Each indicator
iagnosis of thyroid cancer per 100,000 individuals in Si-Gun-Gu
Table 1 Distribution of person-years by diagnosis of thyroid cancer
Variables Total patients Patients with thyroid fine-needle
aspiration biopsy
Diagnosed None P-value Diagnosed None P-value
N/Mean %/SD N/Mean %/SD N/Mean %/SD N/Mean %/SD
Regional variables
Number of thyroid fine-needle aspiration biopsies
in Si-Gun-Gu (per 100,000 people)
348.2 225.0 253.3 207.9 <0.0001a 348.2 225.0 425.9 236.8 <.0001a
Financial independence rate of local government (%) 62.2 23.3 62.4 23.6 0.5344a 62.2 23.3 59.4 22.9 <.0001a
Individual variables
Sex
Male 1140 0.02 5,514,264 99.98 <0.0001b 1140 22.04 4033 77.96 0.1968b
Female 5479 0.10 5,503,665 99.90 5479 21.23 20,327 78.77
Age (years)
0–19 30 0.00 2,622,533 100.00 <0.0001b 30 21.58 109 78.42 <0.0001b
20–29 339 0.02 1,580,567 99.98 339 26.26 952 73.74
30–39 1210 0.07 1,866,884 99.94 1210 26.86 3295 73.14
40–49 1972 0.10 1,909,614 99.90 1972 23.69 6352 76.31
50–59 1819 0.13 1,392,449 99.87 1819 19.48 7519 80.52
60–69 876 0.10 894,668 99.90 876 16.65 4386 83.35
70–79 320 0.06 543,227 99.94 320 16.82 1582 83.18
80+ 53 0.03 207,987 99.98 53 24.31 165 75.69
Type of insurance coverage
Medical Aid 144 0.04 383,596 99.96 <0.0001b 144 34.37 275 65.63 <0.0001b
NHI (self-employed) 2142 0.05 4,060,517 99.95 2142 21.69 7734 78.31
NHI (employed) 4333 0.07 6,573,816 99.93 4333 20.95 16,351 79.05
Income (percentiles)
0–29% 873 0.05 1,784,071 99.95 <0.0001b 873 20.45 3395 79.55 0.2938b
30–59% 1310 0.05 2,612,723 99.95 1310 21.49 4785 78.51
60%+ 4436 0.07 6,621,135 99.93 4436 21.52 16,180 78.48
Year
2003 317 0.03 1,016,565 99.97 <0.0001b 317 40.80 460 59.20 <0.0001b
2004 287 0.03 1,015,716 99.97 287 26.70 788 73.30
2005 319 0.03 1,015,929 99.97 319 23.74 1025 76.26
2006 374 0.04 1,001,078 99.96 374 23.29 1232 76.71
2007 497 0.05 1,019,688 99.95 497 22.42 1720 77.58
2008 588 0.06 999,651 99.94 588 22.13 2069 77.87
2009 771 0.08 997,219 99.92 771 24.12 2425 75.88
2010 751 0.08 1,000,753 99.93 751 19.37 3126 80.63
2011 884 0.09 983,859 99.91 884 20.49 3430 79.51
2012 941 0.10 983,065 99.90 941 19.37 3918 80.63
2013 890 0.09 984,406 99.91 890 17.60 4167 82.40
Region (distance from Seoul)
Gangwon-do (100.6 km) 115 0.04 321,209 99.96 <0.0001b 115 20.25 453 79.75 <0.0001b
Gyeonggi-do (40.0 km) 1445 0.06 2,528,926 99.94 1445 21.80 5182 78.20
Gyeongsangnam-do (366.4 km) 335 0.05 653,458 99.95 335 20.68 1285 79.32
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Table 1 Distribution of person-years by diagnosis of thyroid cancer (Continued)
Gyeongsangbuk-do (225.5 km) 303 0.05 595,692 99.95 303 22.35 1053 77.65
Gwangju (295.3 km) 272 0.08 324,124 99.92 272 14.48 1607 85.52
Daegu (288.3 km) 432 0.08 561,837 99.92 432 17.63 2019 82.37
Daejeon (160.9 km) 267 0.08 334,572 99.92 267 28.13 682 71.87
Busan (394.2 km) 440 0.05 807,140 99.95 440 19.32 1837 80.68
Seoul 1504 0.07 2,282,278 99.93 1504 24.78 4566 75.22
Ulsan (395.7 km) 184 0.07 259,663 99.93 184 24.02 582 75.98
Incheon (37.7 km) 265 0.04 606,840 99.96 265 23.47 864 76.53
Jeollanam-do (346.3 km) 382 0.09 429,219 99.91 382 17.54 1796 82.46
Jeollabuk-do (216.9 km) 244 0.06 413,454 99.94 244 18.26 1092 81.74
Jeju-do (541.6 km) 69 0.06 123,336 99.94 69 23.31 227 76.69
Chungcheongnam-do (129.9 km) 226 0.05 437,945 99.95 226 24.73 688 75.27
Chungcheongbuk-do (137.1 km) 136 0.04 338,236 99.96 136 24.16 427 75.84
Total 6619 0.06 11,017,929 99.98 6619 21.37 24,360 78.63
aThe results of analysis of variance (ANOVA) for each continuous variable to compare mean and standard deviation by diagnosis during study period
bThe results of χ2 tests to analyze frequencies of person-years for each categorical variable by diagnosis of thyroid cancer
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and newly diagnosed cases of thyroid cancer using nation-
wide sampling data and identified a positive correlation.
Our results corroborate those of previous studies regarding
the role of certain diagnostic tests, such as ultrasonography,
in increased thyroid cancer diagnoses [22]. However, thy-
roid ultrasonography is not included under NHI coverage.
Although increased diagnoses could be a natural result of
more frequent screening procedures [23, 24], the increased
diagnosis of small papillary thyroid cancer and other non-
fatal thyroid cancers should still be investigated in South
Korea because of a concomitant increase in preventive
medical procedures and changes in thyroid cancer biopsy
criteria [25]. However, regarding the more thyroid fine-
needle aspiration biopsy were inversely associated with
diagnosis of thyroid cancer among patients who received
these biopsy, there might be excessive medical screening
such as biopsy compared to actual diagnosis. Thus, there
are needed to optimal control for guideline related to
implementation of biopsy even if there were some contro-
versies related to that.
The results of our sub-group analyses support our
hypothesis, as the positive association between biopsy
frequency and new cases of thyroid cancer was
greater in patients with higher socioeconomic status,
suggesting that greater accessibility to certain screen-
ing tests directly influences the frequency of cancer
diagnosis [15]. Also, in the results for sub-group ana-
lysis by sex, regarding the incidence of thyroid cancer
in females was higher than males based on previous
studies, the increasing thyroid biopsy might cause to
unnecessary increasing the diagnosis of thyroid cancerbased on the greater positive correlations with diag-
nosis of thyroid cancer in males [18]. Meanwhile,
subgroup analysis results for patients with biopsy
showed that female patients and patients from low
economic status areas had less diagnosis of thyroid
cancer, in contrast to increase in regional biopsy. The
results also suggested that unnecessary biopsy may be
provided for patients at high risk of thyroid cancer or
those with less health information.
Our study’s strengths include the use of national sam-
pling cohort data to identify the relationship between the
number of thyroid fine-needle aspiration biopsies and
increased diagnoses of thyroid cancer. Therefore, our re-
sults are especially helpful for establishing evidence-based
policies for managing thyroid cancer. Second, to our
knowledge, this study is the first published attempt to
investigate the impact of thyroid fine-needle aspiration
biopsy frequency in individual geographic regions with
respect to new cases of thyroid cancer. Previous studies
focused on increased thyroid cancer incidence and
changes in cancer type according to year or due to in-
creased ultrasonography availability [6]. Thus, our findings
could suggest another factor that contributes to more new
thyroid cancer cases in South Korea. Third, our study ana-
lyzed the relationship between thyroid biopsies and thy-
roid cancer diagnoses adjusting for other covariates, such
as socioeconomic status. Although other studies have
linked increased thyroid cancer with differences in
socioeconomic-related healthcare accessibility [15], we
further analyzed the effects of income level, type of insur-
ance coverage, and financial independence rate of the local
government in this study.
Table 2 Poisson regression analysis results for diagnosis for thyroid cancer
Variables Total patients Patients with thyroid
fine-needle aspiration biopsy
RRa 95% CI P-value RRa 95% CI P-value
Regional variables
Number of thyroid fine-needle aspiration biopsy in Si-Gun-Gu
(per 100,000 people; per 100 increase)
1.108 1.090 1.126 <0.0001 0.973 0.952 0.995 0.0143
Financial independence rate of local government (per 10%) 1.037 0.955 1.125 0.3849 1.003 0.992 1.015 0.5599
Individual variables
Sex
Male 0.206 0.194 0.220 <0.0001 1.075 0.990 1.168 0.0852
Female 1.000 - - - 1.000 - - -
Age (years)
0–19 0.059 0.038 0.093 <0.0001 1.359 0.703 2.627 0.3613
20–29 1.155 0.864 1.543 0.3313 1.700 1.065 2.713 0.0263
30–39 3.334 2.532 4.391 <0.0001 1.796 1.142 2.824 0.0113
40–49 5.389 4.100 7.082 <0.0001 1.519 0.968 2.385 0.0689
50–59 6.430 4.892 8.450 <0.0001 1.219 0.776 1.913 0.3897
60–69 4.721 3.578 6.230 <0.0001 0.921 0.584 1.453 0.7245
70–79 2.542 1.901 3.398 <0.0001 0.858 0.535 1.376 0.5248
80+ 1.000 - - - 1.000 - - -
Type of insurance coverage
Medical Aid 0.768 0.642 0.919 0.0040 1.466 1.101 1.952 0.0087
NHI (self-employed) 0.785 0.745 0.827 <0.0001 1.014 0.947 1.085 0.6984
NHI (employed) 1.000 - - - 1.000 - - -
Income (percentiles)
0–29% 0.640 0.591 0.692 <0.0001 0.879 0.794 0.974 0.0135
30–59% 0.725 0.682 0.771 <0.0001 0.965 0.892 1.045 0.3839
60%+ 1.000 - - - 1.000 - - -
Year
2003 1.000 - - - 1.000 - - -
2004 0.853 0.727 1.001 0.0517 0.784 0.597 1.029 0.0795
2005 0.907 0.776 1.060 0.2187 0.770 0.593 1.000 0.0500
2006 1.029 0.885 1.197 0.7092 0.878 0.686 1.125 0.3051
2007 1.258 1.086 1.456 0.0022 0.924 0.727 1.174 0.5179
2008 1.438 1.243 1.664 <0.0001 0.927 0.730 1.178 0.5372
2009 1.765 1.530 2.035 <0.0001 1.023 0.807 1.297 0.8505
2010 1.583 1.361 1.842 <0.0001 0.870 0.680 1.112 0.2646
2011 1.757 1.509 2.045 <0.0001 1.026 0.804 1.309 0.8379
2012 1.725 1.477 2.015 <0.0001 1.041 0.813 1.332 0.7510
2013 1.579 1.345 1.854 <0.0001 1.067 0.830 1.371 0.6152
Region (distance from Seoul)
Gangwon-do (100.6 km) 1.001 0.662 1.515 0.9960 0.999 0.557 1.789 0.9959
Gyeonggi-do (40.0 km) 1.192 1.042 1.364 0.0107 0.955 0.792 1.151 0.6277
Gyeongsangnam-do (366.4 km) 1.234 0.925 1.647 0.1526 1.130 0.760 1.680 0.5457
Gyeongsangbuk-do (225.5 km) 1.293 0.882 1.897 0.1879 1.322 0.777 2.249 0.3028
Gwangju (295.3 km) 1.435 1.124 1.832 0.0037 0.882 0.634 1.226 0.4537
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Daegu (288.3 km) 1.325 1.099 1.598 0.0032 1.106 0.850 1.437 0.4539
Daejeon (160.9 km) 1.735 1.451 2.075 <0.0001 1.445 1.130 1.848 0.0033
Busan (394.2 km) 1.048 0.883 1.244 0.5927 1.238 0.974 1.574 0.0810
Seoul 1.238 1.003 1.528 0.0468 1.038 0.776 1.388 0.7999
Ulsan (395.7 km) 1.354 1.121 1.636 0.0017 1.370 1.074 1.746 0.0111
Incheon (37.7 km) 1.000 - - -
Jeollanam-do (346.3 km) 1.774 1.150 2.737 0.0095 1.387 0.751 2.562 0.2954
Jeollabuk-do (216.9 km) 1.398 0.924 2.113 0.1125 1.263 0.710 2.245 0.4275
Jeju-do (541.6 km) 1.535 0.996 2.366 0.0522 1.436 0.794 2.598 0.2315
Chungcheongnam-do (129.9 km) 1.383 0.982 1.946 0.0633 1.239 0.772 1.990 0.3746
Chungcheongbuk-do (137.1 km) 1.130 0.780 1.636 0.5188 0.960 0.564 1.634 0.8805
QIC 99756.63 24319.41
aRelative risk for diagnosis of thyroid cancer, based on the results of Poisson regression analysis with GEE adjusted for individual- and regional-level characteristic
to identify the relationship between regional thyroid fine-needle biopsy rates and diagnosis of thyroid cancer
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considered the types and size of thyroid cancer and ac-
cessibility to ultrasonography as important factors in
over-diagnosis. However, we were unable to include
these variables because these data were not available in
the NHI database. Second, to identify overdiagnosis of
cancer, information such as types and stages of thyroid
cancer would be important. However, due to limited
data, we could not identify such factors. Third, patients’
participation in the health checkup program could con-
tribute to over-diagnosis of thyroid cancer, but we could
not identify which patients were diagnosed with thyroidFig. 3 Results of subgroup analysis for all patients. *Results of subgroup analyse
diagnosis of thyroid cancer among total patients according to sex, incom
number of thyroid fine-needle aspiration biopsies. Relative risk (RR) was calculate
regional-level characteristics. Results were considered statistically significant if eacancer through this program due to data limitations,
even though incidence rates increased by year. Finally,
income level data were only collected as units of 10th per-
centiles. Because income level appears to be a significant
factor in thyroid cancer over-diagnosis, more specific in-
come information for each patient could strengthen are
study.
Despite these limitations, our findings suggest that in-
creased numbers of thyroid fine- needle aspiration biopsies
per 100,000 patients by geographic region could contribute
to increased diagnoses of thyroid cancer in South Korea.
Specifically, such relationships were more significant ins for the relationship between thyroid fine-needle aspiration biopsy and
e, financial independence rate of the local government, and median
d using Poisson regression analysis with GEE adjusted for individual- and
ch bar marked to SD did not reach the cutoff line of 1.00
Fig. 4 Results of subgroup analysis for patients who underwent thyroid fine-needle biopsy. * Results of subgroup analyses for the relationship
between thyroid fine-needle aspiration biopsy and diagnosis of thyroid cancer only among patients who underwent thyroid fine-needle biopsy
according to sex, income, financial independence rate of the local government, and median number of thyroid fine-needle aspiration biopsies.
Relative risk (RR) was calculated by Poisson regression analysis with GEE adjusted for individual- and regional-level characteristics. Results were
considered statistically significant if each bar marked to SD did not reach the cutoff line of 1.00
Cho et al. BMC Cancer  (2017) 17:114 Page 9 of 10males, patients with higher socioeconomic status, and in
patients from regions with relatively less accessibility to bi-
opsies. In addition, we also found that some excessive biop-
sies might be provided for people without increasing
diagnosis among patients who received biopsies. The in-
creased incidence of new thyroid cancer cases by year ne-
cessitates guidelines for optimal control and diagnosis of
thyroid cancer and should prompt healthcare professionals
and policy makers to consider the factors that contribute to
excessive diagnosis of asymptomatic and nonfatal thyroid
cancer.Conclusion
Our findings suggest that a higher number of thyroid
fine-needle aspiration biopsies in each Si-Gun-Gu is
positively associated with increased diagnoses of thyroid
cancer in South Korean patients. We recommend that
healthcare professionals and policy makers implement
alternate preventive strategies to thyroid fine-needle
aspiration biopsies during health checkup program
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